![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Bischoff, Monika; Zimny, Sebastian; Feiner, Sebastian; Sauter, Johannes; Sydor, Svenja; Denk, Gerald; Nagel, Jutta M.; Bischoff, Gert; Rust, Christian und Hohenester, Simon 
ORCID: https://orcid.org/0000-0002-9982-6317
(2022):
Multidisciplinary lifestyle intervention is associated with improvements in liver damage and in surrogate scores of NAFLD and liver fibrosis in morbidly obese patients.
In: European Journal of Nutrition, Bd. 61, Nr. 5: S. 2725-2735
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-9982-6317
(2022):
Multidisciplinary lifestyle intervention is associated with improvements in liver damage and in surrogate scores of NAFLD and liver fibrosis in morbidly obese patients.
In: European Journal of Nutrition, Bd. 61, Nr. 5: S. 2725-2735
[PDF, 1MB]
Weigl, Korbinian; Tikk, Kaja; Hoffmeister, Michael; Hampe, Jochen; Igel, Svitlana; Kolligs, Frank; Klug, Stefanie J.; Mansmann, Ulrich; Müller, Oliver; Nagel, Jutta M.; Pichler, Marcus; Schwab, Matthias; Schweigler, Dirk; Stephan, Anna-Magdalena; Toni, Enrico N. de und Brenner, Hermann
(2019):
Prevalence of a First-Degree Relative with Colorectal Cancer and Uptake of Screening Among Persons 40 to 54 Years Old.
In: Clinical Gastroenterology and Hepatology, Bd. 18, Nr. 11: S. 2535-2543
Wu, Liya; Piotrowski, Katja; Rau, Tiina; Waldmann, Elisa; Broedl, Uli C.; Demmelmair, Hans; Koletzko, Berthold; Stark, Renee G.; Nagel, Jutta M.; Mantzoros, Christos S. und Parhofer, Klaus G.
(2014):
Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: a randomized controlled cross-over clinical trial.
In: Metabolism: clinical and experimental, Bd. 63, Nr. 3: S. 382-391
Broedl, Uli C.; Lehrke, Michael; Fleischer-Brielmaier, Elisabeth; Tietz, Anne B.; Nagel, Jutta M.; Göke, Burkhard; Lohse, Peter und Parhofer, Klaus G.
(2006):
Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome.
In: Cardiovascular Diabetology
5:11
[PDF, 284kB]